Money is not "pouring" into PPHM IMO, because the small universe of microbio investors probably doesn't know much more than that PPHM shot up briefly to $5.50 and then quickly tanked due to some big problem with the 2nd Line NSCLC trial. Beyond that I suspect there are only a handful of microbio investors, other than the fanatics on this board, who know much about Peregrine.
I hope we on this board know as much as we think we know. What I think we know is that Peregrine has three Phase II trials, one completed, that have or soon will report MOS numbers significantly in excess of the SOC in two killer cancers. We also "know" Peregrine is attracting attention of buyers/partners and the Peregrine will be interacting with the FDA on Bavi 2nd Line NSCLC Phase III trials.
If we are wrong about these things, there will be a lot of "pooring" among us.
Paul
News 
Market Data 
Discover 
